FDA
-
-
-
-
-
-
-
Kezar Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Kezar Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Kezar Life Sciences (KZR) Receives FDA Clearance of IND for Zetomipzomib for the Treatment of Autoimmune Hepatitis
-
-
-
-
-
-
-
Kezar Life Sciences Reports Fourth Quarter and Year End 2020 Financial Results and Provides Business Updates
-
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

